19 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
in the EU, many Asian countries, and other jurisdictions, we must obtain separate regulatory approvals and comply with numerous and varying regulatory
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
.
In addition to regulations in the U.S., to market and sell our diagnostic tests and therapeutic products in the EU, many Asian countries, and other
424B5
pv4gihdu cccib3
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
m13 dvs1hrlu5vc
7 Mar 24
Prospectus supplement for primary offering
9:57pm
424B5
tzap98y3wot2
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
bh1dvu
16 Nov 23
Shelf registration
5:23pm
DRS
4fmy5rt6 hiffj
14 Aug 23
Draft registration statement
12:00am
424B4
wmo wcohc304nm
2 Sep 22
Prospectus supplement with pricing info
3:25pm
S-1
s1687
25 Apr 22
IPO registration
6:16am
- Prev
- 1
- Next